Literature DB >> 28366464

Prognostic Value of National Comprehensive Cancer Network Lung Cancer Resection Quality Criteria.

Raymond U Osarogiagbon1, Meredith A Ray2, Nicholas R Faris3, Matthew P Smeltzer4, Carrie Fehnel3, Cheryl Houston-Harris3, Raymond S Signore3, Laura M McHugh3, Paul Levy5, Lynn Wiggins6, Vishal Sachdev7, Edward T Robbins3.   

Abstract

BACKGROUND: The National Comprehensive Cancer Network (NCCN) surgical resection guidelines for non-small cell lung cancer recommend anatomic resection, negative margins, examination of hilar/intrapulmonary lymph nodes, and examination of three or more mediastinal nodal stations. We examined the survival impact of these criteria.
METHODS: A population-based observational study was done using patient-level data from all curative-intent, non-small cell lung cancer resections from 2004 to 2013 at 11 institutions in four contiguous Dartmouth Hospital referral regions in three US states. We used an adjusted Cox proportional hazards model to assess the overall survival impact of attaining NCCN guidelines.
RESULTS: Of 2,429 eligible resections, 91% were anatomic, 94% had negative margins, 51% sampled hilar nodes, and 26% examined three or more mediastinal nodal stations. Only 17% of resections met all four criteria; however, there was a significant increasing trend from 2% in 2004 to 39% in 2013 (p < 0.001). Compared with patients whose surgery missed one or more criteria, the hazard ratio for patients whose surgery met all four criteria was 0.71 (95% confidence interval: 0.59 to 0.86, p < 0.001). Margin status and the nodal staging criteria were most strongly linked with survival.
CONCLUSIONS: Attainment of NCCN surgical quality guidelines was low, but improving, over the past decade in this cohort from a high lung cancer mortality region of the United States. The NCCN quality criteria, especially the nodal examination criteria, were strongly associated with survival. The quality of nodal examination should be a focus of quality improvement in non-small cell lung cancer care.
Copyright © 2017 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28366464      PMCID: PMC5401641          DOI: 10.1016/j.athoracsur.2017.01.098

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  29 in total

1.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

2.  Use of a surgical specimen-collection kit to improve mediastinal lymph-node examination of resectable lung cancer.

Authors:  Raymond U Osarogiagbon; Laura E Miller; Robert A Ramirez; Christopher G Wang; Thomas F O'Brien; Xinhua Yu; Alim Khandekar; Glenn P Schoettle; Samuel G Robbins; Edward T Robbins; Jeffrey B Gibson
Journal:  J Thorac Oncol       Date:  2012-08       Impact factor: 15.609

3.  Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer.

Authors:  Matthew J Schuchert; Brian L Pettiford; Samuel Keeley; Thomas A D'Amato; Arman Kilic; John Close; Arjun Pennathur; Ricardo Santos; Hiran C Fernando; James R Landreneau; James D Luketich; Rodney J Landreneau
Journal:  Ann Thorac Surg       Date:  2007-09       Impact factor: 4.330

4.  Patterns of surgical care of lung cancer patients.

Authors:  Alex G Little; Valerie W Rusch; James A Bonner; Laurie E Gaspar; Mark R Green; W Richard Webb; Andrew K Stewart
Journal:  Ann Thorac Surg       Date:  2005-12       Impact factor: 4.330

5.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

6.  Mediastinal lymph node examination and survival in resected early-stage non-small-cell lung cancer in the surveillance, epidemiology, and end results database.

Authors:  Raymond U Osarogiagbon; Xinhua Yu
Journal:  J Thorac Oncol       Date:  2012-12       Impact factor: 15.609

7.  The influence of hospital volume on survival after resection for lung cancer.

Authors:  P B Bach; L D Cramer; D Schrag; R J Downey; S E Gelfand; C B Begg
Journal:  N Engl J Med       Date:  2001-07-19       Impact factor: 91.245

8.  Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial.

Authors:  Gail E Darling; Mark S Allen; Paul A Decker; Karla Ballman; Richard A Malthaner; Richard I Inculet; David R Jones; Robert J McKenna; Rodney J Landreneau; Valerie W Rusch; Joe B Putnam
Journal:  J Thorac Cardiovasc Surg       Date:  2011-03       Impact factor: 5.209

9.  Limited Resection Versus Lobectomy for Older Patients With Early-Stage Lung Cancer: Impact of Histology.

Authors:  Rajwanth R Veluswamy; Nicole Ezer; Grace Mhango; Emily Goodman; Marcelo Bonomi; Alfred I Neugut; Scott Swanson; Charles A Powell; Mary B Beasley; Juan P Wisnivesky
Journal:  J Clin Oncol       Date:  2015-08-03       Impact factor: 44.544

10.  Prevalence, Prognostic Implications, and Survival Modulators of Incompletely Resected Non-Small Cell Lung Cancer in the U.S. National Cancer Data Base.

Authors:  Raymond U Osarogiagbon; Chun Chieh Lin; Matthew P Smeltzer; Ahmedin Jemal
Journal:  J Thorac Oncol       Date:  2016-01       Impact factor: 15.609

View more
  12 in total

1.  Visiting an old foe: distant recurrence following R0 lobectomy for pathological N0 lung adenocarcinoma.

Authors:  Sameer A Hirji; Thomas A D'Amico
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

2.  Effectiveness of Implemented Interventions on Pathologic Nodal Staging of Non-Small Cell Lung Cancer.

Authors:  Meredith A Ray; Nicholas R Faris; Matthew P Smeltzer; Carrie Fehnel; Cheryl Houston-Harris; Paul Levy; Lynn Wiggins; Vishal Sachdev; Todd Robbins; David Spencer; Raymond U Osarogiagbon
Journal:  Ann Thorac Surg       Date:  2018-03-11       Impact factor: 4.330

3.  Survival Before and After Direct Surgical Quality Feedback in a Population-Based Lung Cancer Cohort.

Authors:  Matthew P Smeltzer; Nicholas R Faris; Meredith A Ray; Carrie Fehnel; Cheryl Houston-Harris; Philip Ojeabulu; Olawale Akinbobola; Yu-Sheng Lee; Meghan Meadows; R Samuel Signore; Lynn Wiggins; David Talton; Edmond Owen; Lawrence E Deese; Richard Eubanks; Bradley A Wolf; Paul Levy; E Todd Robbins; Raymond U Osarogiagbon
Journal:  Ann Thorac Surg       Date:  2018-12-27       Impact factor: 4.330

4.  Comparative Effectiveness of a Lymph Node Collection Kit Versus Heightened Awareness on Lung Cancer Surgery Quality and Outcomes.

Authors:  Meredith A Ray; Carrie Fehnel; Olawale Akinbobola; Nicholas R Faris; Meghan Taylor; Alicia Pacheco; Matthew P Smeltzer; Raymond U Osarogiagbon
Journal:  J Thorac Oncol       Date:  2021-02-12       Impact factor: 15.609

5.  Spanish Lung Cancer Group SCAT trial: surgical audit to lymph node assessment based on IASLC recommendations.

Authors:  José Ramón Jarabo Sarceda; Sergio Bolufer Nadal; Roberto Mongil Poce; Pedro López de Castro; Ramón Moreno Balsalobre; Juan Carlos Peñalver Cuesta; Raul Embún Flor; Joaquín Pac Ferrer; Francisco Javier Algar Algar; Antonio Pablo Gámez García; Marcelo F Jiménez; Jesús Gabriel Sales-Badía; Eva Pereira; Bartomeu Massuti; Mariano Provencio; Florentino Hernando Trancho
Journal:  Transl Lung Cancer Res       Date:  2021-04

6.  Closing the gap: Contribution of surgical best practices to outcome differences between high- and low-volume centers for lung cancer resection.

Authors:  Mitchell S von Itzstein; Rong Lu; Kemp H Kernstine; Ethan A Halm; Shidan Wang; Yang Xie; David E Gerber
Journal:  Cancer Med       Date:  2020-04-21       Impact factor: 4.452

7.  Ex Vivo Assessment of Tumor-Targeting Fluorescent Tracers for Image-Guided Surgery.

Authors:  Fortuné M K Elekonawo; Jan Marie de Gooyer; Desirée L Bos; David M Goldenberg; Otto C Boerman; Lodewijk A A Brosens; Andreas J A Bremers; Johannes H W de Wilt; Mark Rijpkema
Journal:  Cancers (Basel)       Date:  2020-04-17       Impact factor: 6.639

8.  Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non-Small Cell Lung Cancer After Resection With Curative Intent.

Authors:  Matthew P Smeltzer; Nicholas R Faris; Meredith A Ray; Raymond U Osarogiagbon
Journal:  JAMA Oncol       Date:  2018-01-01       Impact factor: 31.777

9.  Trends in Accuracy and Comprehensiveness of Pathology Reports for Resected NSCLC in a High Mortality Area of the United States.

Authors:  Matthew P Smeltzer; Yu-Sheng Lee; Nicholas R Faris M Div; Carrie Fehnel; Olawale Akinbobola; Meghan Meadows-Taylor; David Spencer; Elizabeth Sales; Sherry Okun; Christopher Giampapa; Amal Anga; Alicia Pacheco; Meredith A Ray; Raymond U Osarogiagbon
Journal:  J Thorac Oncol       Date:  2021-07-16       Impact factor: 20.121

10.  Positive Surgical Margins in the 10 Most Common Solid Cancers.

Authors:  Ryan K Orosco; Viridiana J Tapia; Joseph A Califano; Bryan Clary; Ezra E W Cohen; Christopher Kane; Scott M Lippman; Karen Messer; Alfredo Molinolo; James D Murphy; John Pang; Assuntina Sacco; Kathryn R Tringale; Anne Wallace; Quyen T Nguyen
Journal:  Sci Rep       Date:  2018-04-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.